$ATI

Fields Kimberly A sold $364K of ATI

Fields Kimberly A (Chair, President and CEO) sold 2,000 shares of ATI INC (ATI) at $181.90 ($0.36M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fields Kimberly A
Published Jun 4, 2026, 11:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATI
Neutral
medium confidence
Mentioned
$ATI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATINeutralLow
01

Why it matters

The disclosure may slightly pressure sentiment, but without new company fundamentals it is unlikely to drive a durable repricing.

02

Market read

Traders may monitor for follow-on insider activity, but this specific filing is not a standalone fundamental catalyst.

03

What to watch

The article provides only the sale details; it does not indicate whether other insiders/large holders increased positions or whether ATI had concurrent fundamental developments.

Relevance 6/10Novelty 6/10Timing: Filed June 4; sale executed June 2 (10b5-1).

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by ATI’s Chair/President/CEO under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$ATINeutralMedium confidence
Context

ATI CEO/Chair Kimberly A. Fields sold 2,000 shares in an open-market transaction under a pre-arranged 10b5-1 plan on June 2.

Expected impact

Likely limited near-term impact; any effect is more about sentiment than fundamentals.

Evidence & confidence

The filing is a routine 10b5-1 sale by an insider, with no accompanying fundamental catalyst (earnings, guidance, deal, or litigation) in the article.

Market effects

No sector read-through provided; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than a negative view on ATI.

Key entities

  • ATI

    ATI Inc.; recipient of the insider transaction disclosure.

  • Kimberly A. Fields

    Chair, President and CEO who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.

$ATIHighAI 9/10

ATI (ATI) Q2 2026 Earnings Call Transcript

ATI reported Q2 2026 results in an earnings call. Revenue rose 11% to $1,261.1 million, with adjusted EBITDA up 37% to $284.4 million and margin expanding to 22.6%. Backlog reached a record $4.4 billion. Adjusted EPS was $1.23. Full-year 2026 guidance: adjusted EBITDA $1.135B-$1.185B and adjusted EPS $4.90-$5.18.